Study profile: infants aged 1–20 days assessed for jaundice and, among eligible neonates, numbers with serum bilirubin measured and with hyperbilirubinaemia, by study location and overall
| Study location | Overall | ||||||
| Dhaka | Delhi | Chandigarh | Durban | Kumasi | La Paz | ||
| Number assessed for jaundice* | 448 | 330 | 700 | 414 | 457 | 293 | 2642 |
| Preterm birth | 42 | 36 | 36 | 42 | 30 | 10 | 196 |
| % of infants | 9% | 11% | 5% | 10% | 7% | 3% | 7% |
| Age group strata | |||||||
| 1–6 days | 268 | 94 | 347 | 61 | 148 | 100 | 1018 |
| % of infants | 60% | 28% | 50% | 15% | 32% | 34% | 39% |
| 7–20 days | 180 | 236 | 353 | 353 | 309 | 193 | 1624 |
| % of infants | 40% | 72% | 50% | 85% | 68% | 66% | 61% |
| Any jaundice observed by study physicians | 198 | 148 | 398 | 160 | 147 | 190 | 1241 |
| % of assessed | 44% | 45% | 57% | 39% | 32% | 65% | 47% |
| Serum bilirubin obtained | 81 | 119 | 379 | 132 | 71 | 180 | 962 |
| % of those with jaundice | 41% | 80% | 95% | 91% | 48% | 95% | 78% |
| Serum bilirubin >260 µmol /L (15 mg/dL) | 36 | 62 | 39 | 19 | 18 | 104 | 278 |
| % of those with bilirubin measured | 44% | 52% | 10% | 14% | 25% | 58% | 29% |
| Serum bilirubin >340 µmol /L (20 mg/dL) | 14 | 26 | 9 | 2 | 8 | 36 | 95 |
| % of those with bilirubin measured | 17% | 22% | 2% | 2% | 11% | 20% | 10% |
*By both primary healthcare workers and physicians.